By Matthew Keck —
The University of Louisville’s acquisition of KentuckyOne assets may already be having an impact.
U of L health care leaders affirmed their intentions to save the Jewish Hospital heart transplant program on Aug. 14. This was the same day U of L announced their plans to purchase KentuckyOne’s assets.
Dr. Mark S. Slaughter, head of the program at Jewish Hospital, told the Courier Journal that he intends to stay with the university to see that this happens.
The program is set to be suspended on Aug. 17 and inactive for at least 12 months or indefinitely.